RJA
HQH

Raymond James & Associates’s abrdn Healthcare Investors HQH Stock Holding History

Raymond James & Associates’s Portfolio HQH Stock Details HQH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$6.61M Buy
355,205
+157,618
+80% +$2.94M ﹤0.01% 1464
2024
Q2 		$3.45M Buy
197,587
+1,847
+0.9% +$30.8K ﹤0.01% 1835
2024
Q1 		$3.3M Buy
195,740
+29,113
+17% +$496K ﹤0.01% 1853
2023
Q4 		$2.76M Sell
166,627
-4,330
-3% -$66.6K ﹤0.01% 1900
2023
Q3 		$2.66M Buy
170,957
+10,033
+6% +$167K ﹤0.01% 1843
2023
Q2 		$2.74M Buy
160,924
+15,464
+11% +$268K ﹤0.01% 1868
2023
Q1 		$2.57M Buy
145,460
+1,759
+1% +$32K ﹤0.01% 1884
2022
Q4 		$2.59M Buy
143,701
+8,173
+6% +$151K ﹤0.01% 1833
2022
Q3 		$2.34M Buy
135,528
+3,798
+3% +$72.6K ﹤0.01% 1874
2022
Q2 		$2.46M Sell
131,730
-82,880
-39% -$1.64M ﹤0.01% 1863
2022
Q1 		$4.46M Sell
214,610
-30,668
-13% -$651K ﹤0.01% 1590
2021
Q4 		$5.83M Sell
245,278
-17,044
-6% -$425K ﹤0.01% 1453
2021
Q3 		$6.71M Sell
262,322
-15,361
-6% -$404K 0.01% 1302
2021
Q2 		$7.14M Buy
277,683
+40,540
+17% +$1,000K 0.01% 1262
2021
Q1 		$5.79M Buy
237,143
+60,155
+34% +$1.47M 0.01% 1331
2020
Q4 		$4.22M Buy
176,988
+63,408
+56% +$1.38M ﹤0.01% 1438
2020
Q3 		$2.34M Buy
113,580
+21,183
+23% +$448K ﹤0.01% 1652
2020
Q2 		$1.97M Sell
92,397
-78
-0.1% -$1.59K ﹤0.01% 1737
2020
Q1 		$1.65M Sell
92,475
-74,943
-45% -$1.48M ﹤0.01% 1687
2019
Q4 		$3.5M Sell
167,418
-51,099
-23% -$1.01M ﹤0.01% 1491
2019
Q3 		$4.01M Sell
218,517
-33,368
-13% -$643K 0.01% 1351
2019
Q2 		$5.06M Sell
251,885
-67,619
-21% -$1.34M 0.01% 1205
2019
Q1 		$6.56M Buy
319,504
+2,132
+0.7% +$43.6K 0.01% 1043
2018
Q4 		$5.7M Sell
317,372
-72,290
-19% -$1.48M 0.01% 1042
2018
Q3 		$9.02M Buy
389,662
+15,554
+4% +$352K 0.01% 885
2018
Q2 		$8.04M Buy
374,108
+31,355
+9% +$667K 0.01% 927
2018
Q1 		$7.38M Buy
342,753
+24,358
+8% +$561K 0.01% 941
2017
Q4 		$7.18M Buy
318,395
+97,501
+44% +$2.28M 0.01% 933
2017
Q3 		$5.57M Buy
220,894
+15,534
+8% +$390K 0.01% 1024
2017
Q2 		$5.16M Buy
205,360
+11,926
+6% +$295K 0.01% 1018
2017
Q1 		$4.65M Buy
193,434
+7,496
+4% +$176K 0.01% 1055
2016
Q4 		$3.93M Buy
185,938
+75,436
+68% +$1.68M 0.01% 1113
2016
Q3 		$2.63M Buy
110,502
+18,254
+20% +$459K 0.01% 1297
2016
Q2 		$2.16M Buy
92,248
+24,116
+35% +$598K 0.01% 1285
2016
Q1 		$1.64M Buy
68,132
+12,816
+23% +$305K 0.01% 1396
2015
Q4 		$1.64M Buy
55,316
+13,939
+34% +$430K 0.01% 1370
2015
Q3 		$1.14M Sell
41,377
-295
-0.7% -$10K ﹤0.01% 1529
2015
Q2 		$1.45M Sell
41,672
-1,372
-3% -$47.6K 0.01% 1521
2015
Q1 		$1.47M Sell
43,044
-3,460
-7% -$116K 0.01% 1434
2014
Q4 		$1.43M Buy
46,504
+8,152
+21% +$245K 0.01% 1345
2014
Q3 		$1.06M Buy
38,352
+1,256
+3% +$34K 0.01% 1461
2014
Q2 		$956K Buy
37,096
+13,038
+54% +$340K 0.01% 1522
2014
Q1 		$640K Buy
24,058
+566
+2% +$15.7K ﹤0.01% 1668
2013
Q4 		$620K Sell
23,492
-5,989
-20% -$147K ﹤0.01% 1570
2013
Q3 		$691K Sell
29,481
-14,872
-34% -$351K 0.01% 1440
2013
Q2 		$997K Buy
+44,353
New +$943K 0.01% 1172

Other funds holding HQH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $1.03T AUM 1% 1-Year Est. Return
SCM
Sage Capital Management Stockton, New Jersey $256M AUM 29.76% 1-Year Est. Return

Raymond James & Associates's HQH Position: Q3 2024 in Review

Raymond James & Associates increased its abrdn Healthcare Investors (HQH) stake by 80% in Q3 2024, buying an estimated $2.94M and bringing the position to 355,205 shares worth $6.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Raymond James & Associates first reported a position in HQH in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.02M in Q3 2018. 122 funds tracked by Wall St. Rank hold HQH as of Q3 2024.

  • Raymond James & Associates held 355,205 shares of abrdn Healthcare Investors worth $6.61M as of Q3 2024.
  • Raymond James & Associates bought 157,618 abrdn Healthcare Investors shares in Q3 2024, an estimated $2.94M.
  • abrdn Healthcare Investors made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1464 holding.
  • Raymond James & Associates first reported a position in abrdn Healthcare Investors in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's abrdn Healthcare Investors position peaked at $9.02M in Q3 2018.
  • 122 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.